论文部分内容阅读
目的:探讨三联液雾化吸入治疗气管支气管结核过程中的临床效果。方法:选取2011年12月至2013年12月在我院接受气管支气管结核治疗的患者52例研究对象,随机分为观察组和对照组,每组26例患者,对照组患者给予单纯的全身化疗治疗,观察组在对照组患者的基础上加用三联液雾化吸入治疗,比较两组患者的治疗效果。结果:观察组患者临床治疗的有效率明显优于对照组,具有统计学意义(p<0.05)。结论:在对气管支气管结核患者实施治疗的过程中,在全身化疗治疗的基础上给予三联液雾化吸入治疗可以提高临床治疗的有效率,具有显著的效果,值得临床推广。
Objective: To investigate the clinical effect of triple liquid atomization inhalation in the treatment of tracheobronchial tuberculosis. Methods: Fifty-two subjects who were treated with tracheobronchial tuberculosis in our hospital from December 2011 to December 2013 were randomly divided into observation group and control group, with 26 patients in each group. Patients in the control group were given systemic chemotherapy Treatment, observation group in the control group based on the use of triple liquid atomization inhalation therapy, the treatment effect of two groups were compared. Results: The effective rate of clinical treatment in observation group was significantly better than that in control group, with statistical significance (p <0.05). Conclusion: In the treatment of patients with tracheobronchial tuberculosis during the treatment of systemic chemotherapy based on the triple liquid atomization inhalation therapy can improve the efficiency of clinical treatment, with significant results, worthy of clinical promotion.